Healthcare Of Ontario Pension Plan Trust Fund Neurocrine Biosciences Inc Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$40.7 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $181,764 - $198,890	-1,389 Reduced 6.41%	20,271 $2.79 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $6.43 Million - $7.09 Million	-49,340 Reduced 69.49%	21,660 $2.99 Million
Q4 2023 Mar 21, 2024	BUY	$106.07 - $132.76 $7.53 Million - $9.43 Million	71,000 New	71,000 $9.35 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $194,807 - $254,651	2,070 Added 9.25%	24,445 $2.47 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $129,771 - $154,504	1,216 Added 5.75%	22,375 $2.67 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $1.94 Million - $2.27 Million	21,089 Added 30127.14%	21,159 $2.25 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $5,305 - $7,004	70 New	70 $7,000
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $854,910 - $1.12 Million	-11,800 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $939,870 - $1.25 Million	11,800 New	11,800 $1.01 Million
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $22,234 - $25,549	-258 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$89.43 - $102.27 $66,535 - $76,088	-744 Reduced 74.25%	258 $25,000
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $87,745 - $119,638	1,002 New	1,002 $97,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account